Fundraising FoxRelief Cardiovascular
Costa Mesa, US · 4 known investors
Find your way into Relief Cardiovascular
Sign up to see every warm intro you have to Relief Cardiovascular
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Relief Cardiovascular team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Relief Cardiovascular develops transcatheter smart implant systems for volume management in congestive heart failure, including the Relief System, a preload-modulating implant for inferior vena cava flow modulation with autonomous hemodynamic monitoring. It targets heart failure patients with diuretic-resistant congestion whose needs are inadequately met by pharmaceuticals and legacy devices.
Investors · 4
How we know: Advent Life Sciences's portfolio page · the company's own site · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · Broadview Ventures's portfolio page · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Good Growth Capital's portfolio page · the company's own site · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Funding
SEC filings, press & company announcements$12M disclosed across 1 of 2 rounds · 2025
- $12MSeries AJan 2025 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Relief Cardiovascular do?
- Relief Cardiovascular develops transcatheter smart implant systems for volume management in congestive heart failure, including the Relief System, a preload-modulating implant for inferior vena cava flow modulation with autonomous hemodynamic monitoring. It targets heart failure patients with diuretic-resistant congestion whose needs are inadequately met by pharmaceuticals and legacy devices.
- Who are Relief Cardiovascular's investors?
- Relief Cardiovascular's investors include Advent Life Sciences, Broadview Ventures, Good Growth Capital, Vensana Capital.
- How much funding has Relief Cardiovascular raised?
- Relief Cardiovascular has disclosed $12M raised across 1 of its 2 known rounds.
- Where is Relief Cardiovascular headquartered?
- Relief Cardiovascular is headquartered in Costa Mesa, US.